Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative

symbol logo$BBNX Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.52 down -57.58% YoY • Reported revenue of $35.51M up 30.31% YoY • Beta Bionics estimates FY2026 total revenue of approximately $124M to $126M, gross margin of 58.5% to 59.5%, and 37% to 39% of new patient starts reimbursed through PBP.
1

Price since post

Full Details

Advertisement|Remove ads.